Eli Lilly (LLY) Dividends payables Growth (3y) (2012 - 2025)

Eli Lilly (LLY) Dividends payables Growth (3y) (2012 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 15.10%
Dec 31, 2024 14.99%
Jun 30, 2024 14.94%
Dec 31, 2023 14.91%
Dec 31, 2022 14.85%
Jun 30, 2022 14.10%
Dec 31, 2021 10.81%
Jun 30, 2021 10.06%
Dec 31, 2020 9.27%
Dec 31, 2019 7.00%
Jun 30, 2019 3.38%
Dec 31, 2018 6.48%
Jun 30, 2018 3.00%
Dec 31, 2017 3.66%
Jun 30, 2017 1.47%
Dec 31, 2016 1.54%
Jun 30, 2016 0.66%
Dec 31, 2015 -0.15%
Jun 30, 2015 -0.89%
Dec 31, 2014 -0.74%